文献速递肿瘤 PET/CT放射性药物与辐射防护

PET体内定量偏差的测量:患者血液样本与影像浓度的对照研究

Measurement of PET Quantitative Bias In Vivo.
PubMed 文献 · J Nucl Med · 2020-10-09

该研究以10例前列腺癌患者为对象,比较降主动脉PET影像-derived放射性浓度与校准γ计数器全血计数的差异。结果显示两者线性相关R²为0.985,平均差异4.8%±8.6%,PET测量倾向偏高。作者认为该偏差或部分源于残余未校正散射或衰减校正误差,为体内PET偏差评估提供了依据。

要点

  • PET影像与γ计数器血液浓度线性相关R²=0.985。
  • 平均差异4.8%±8.6%,PET测量值倾向偏高。
  • 偏差可能部分源于残余散射或衰减校正误差。

核心结论

  • 在常规全身PET/CT临床协议下,患者影像数据与校准γ计数器血样计数的差异平均约5%。

研究设计与样本

  • 研究纳入10例前列腺癌患者,使用18F-FDCPyL PET/CT,单次给药后采集3个全身PET/CT图像序列(注射后不久及约1小时和4小时后)。
  • 在8小时内采集8个时间点静脉血样,用NaI γ计数器计数全血,并以三指数函数拟合估算各PET采集时刻的放射性浓度。
  • 在降胸主动脉放置直径10mm、长20mm的圆柱形感兴趣区,估算PET-derived血液放射性浓度,与γ计数器数据比较。

主要发现

  • PET-derived与γ计数器-derived放射性浓度在相关浓度范围内呈线性关系,R²为0.985。
  • PET与γ计数器数据的平均差异为4.8%±8.6%,PET测量值倾向偏高。
  • 作者认为该偏差可能部分归因于残余未校正散射或衰减校正误差。

临床怎么用

  • 在解读基于常规全身PET/CT的定量影像生物标志物时,应意识到体内定量可能存在约5%的平均偏差。
  • 可利用患者血样γ计数器计数作为体内参考,评估PET定量偏差。

局限性

  • 研究仅纳入10例前列腺癌患者,样本量有限。
  • 偏差来源未完全明确,可能涉及残余散射或衰减校正误差。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Quantitative imaging biomarkers are widely used in PET for both research and clinical applications, yet bias in the underlying image data has not been well characterized. In the absence of a readily available reference standard for in vivo quantification, bias in PET images has been inferred using physical phantoms, even though arrangements of this sort provide only a poor approximation of the imaging environment in real patient examinations. In this study, we used data acquired from patient volunteers to assess PET quantitative bias in vivo. Image-derived radioactivity concentrations in the descending aorta were compared with blood samples counted on a calibrated γ-counter. Methods: Ten patients with prostate cancer were studied using 2-(3-(1-carboxy-5-[(6-18F-fluoro-pyridine-3-carbonyl)-amino]-pentyl)-ureido)-pentanedioic acid PET/CT. For each patient, 3 whole-body PET/CT image series were acquired after a single administration of the radiotracer: shortly after injection as well as approximately 1 and 4 h later. Venous blood samples were obtained at 8 time points over an 8-h period, and whole blood was counted on a NaI γ-counter. A 10-mm-diameter, 20-mm-long cylindric volume of interest was positioned in the descending thoracic aorta to estimate the PET-derived radioactivity concentration in blood. A triexponential function was fit to the γ-counter blood data and used to estimate the radioactivity concentration at the time of each PET acquisition. Results: The PET-derived and γ-counter-derived radioactivity concentrations were linearly related, with an R2 of 0.985, over a range of relevant radioactivity concentrations. The mean difference between the PET and γ-counter data was 4.8% ± 8.6%, with the PET measurements tending to be greater. Conclusion: Human image data acquired on a conventional whole-body PET/CT system with a typical clinical protocol differed by an average of around 5% from blood samples counted on a calibrated γ-counter. This bias may be partly attributable to residual uncorrected scatter or attenuation correction error. These data offer an opportunity for the assessment of PET bias in vivo and provide additional support for the use of quantitative imaging biomarkers.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Lodge MA, Lesniak W, Gorin MA, et al. Measurement of PET Quantitative Bias In Vivo. J Nucl Med. 2020. PMID: 33037089. doi:10.2967/jnumed.120.251397

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。